OBJECTIVE: To assess General Pratictioner's (GPs) knowledge and attitudes about HPV infection and prevention. DESIGN AND PARTICIPANTS: A semi-structured survey was conducted from November to December 2013 among Italian GPs. Descriptive and univariate analyses were carried out. MAIN OUTCOME MEASURES AND RESULTS: 938 GPs were included in the study. 15% participated in continuing medical education courses focusing on HPV. GPs identified as HPV transmission routes: sexual (100%), cutaneous (15%), transplacental (13%), haematic (9%) and by air (2%); they considered HPV-related diseases: cervical (98%), vulvar and vaginal (42%), anal (39%), penile (38%) and oral (38%) cancer, genital warts (79%) and respiratory papillomatosis (12%). They knew HPV vaccination is to prevent HPV-associated cancer (60%), in particular cervical cancer (35%), genital warts (3%) and sexually transmitted diseases (2%). A total of 73% were aware of the existence of both available vaccines, 69% believed that immunization target population should be females before initiation of sexual activity, 87% knew the age of vaccine administration. No significant difference in knowledge was retrieved by age, gender, level of education or region of origin. CONCLUSION: We report a lack of knowledge on HPV infection and vaccination in GPs. GPs have a key role in the Italian health system. Although 12-year old patients are a small percentage of their patients, it is of fundamental importance to promote medical education and training among GPs in order to meet HPV coverage targets and control HPV-associated diseases.
OBJECTIVE: To assess General Pratictioner's (GPs) knowledge and attitudes about HPV infection and prevention. DESIGN AND PARTICIPANTS: A semi-structured survey was conducted from November to December 2013 among Italian GPs. Descriptive and univariate analyses were carried out. MAIN OUTCOME MEASURES AND RESULTS: 938 GPs were included in the study. 15% participated in continuing medical education courses focusing on HPV. GPs identified as HPV transmission routes: sexual (100%), cutaneous (15%), transplacental (13%), haematic (9%) and by air (2%); they considered HPV-related diseases: cervical (98%), vulvar and vaginal (42%), anal (39%), penile (38%) and oral (38%) cancer, genital warts (79%) and respiratory papillomatosis (12%). They knew HPV vaccination is to prevent HPV-associated cancer (60%), in particular cervical cancer (35%), genital warts (3%) and sexually transmitted diseases (2%). A total of 73% were aware of the existence of both available vaccines, 69% believed that immunization target population should be females before initiation of sexual activity, 87% knew the age of vaccine administration. No significant difference in knowledge was retrieved by age, gender, level of education or region of origin. CONCLUSION: We report a lack of knowledge on HPV infection and vaccination in GPs. GPs have a key role in the Italian health system. Although 12-year old patients are a small percentage of their patients, it is of fundamental importance to promote medical education and training among GPs in order to meet HPV coverage targets and control HPV-associated diseases.
Authors: F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi Journal: Acta Otorhinolaryngol Ital Date: 2018-04 Impact factor: 2.124
Authors: A Odone; S Visciarelli; T Lalic; F Pezzetti; F Spagnoli; C Pasquarella; G Ferrari; C Signorelli Journal: Acta Otorhinolaryngol Ital Date: 2015-12 Impact factor: 2.124
Authors: Matt Lechner; Claire Vassie; Cemal Kavasogullari; Oliver Jones; James Howard; Liam Masterson; Tim Fenton; Wendell Yarbrough; Jo Waller; Richard Gilson Journal: BMJ Open Date: 2018-07-28 Impact factor: 2.692
Authors: Miriam Levi; Paolo Bonanni; Marco Biffino; Michele Conversano; Maria Corongiu; Paolo Morato; Tommasa Maio Journal: Hum Vaccin Immunother Date: 2018-03-30 Impact factor: 3.452